JOURNEY STRATEGIC WEALTH LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1909316 SUMMIT, NJ

Position in SUPN

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$235,808

+$14,595 QoQ

Shares Held

4,562

+2.5% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Mar 31, 2026

JOURNEY STRATEGIC WEALTH LLC holds $1,715,451 across 5 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (13.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	1,026	$608,394
2	ZTS	Zoetis Inc.	2,716	$321,055
3	NBIX	Neurocrine Biosciences Inc	2,355	$310,245
4	VTRS	Viatris Inc	17,761	$239,949
5	SUPN	Supernus Pharmaceuticals, Inc. This page	4,562	$235,808

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$235,808	4,562	+2.5%	Shares	Sole	2026-04-15
2025-12-31	$221,213	4,451	-0.1%	Shares	Sole	2026-02-13
2025-09-30	$212,902	4,455	—	Shares	Sole	2025-11-12
No filing history on record for this holder in this stock.